Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-12 Sale |
2022-08-16 7:03 pm |
Epizyme Inc. | EPZM | Giordano Michael F Director |
17,054 | $0 | $0 | 0 (Direct) |
View |
| 2022-08-12 Sale |
2022-08-16 7:02 pm |
Epizyme Inc. | EPZM | GOLDFISCHER CARL Director |
3,403,005 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2022-08-12 Sale |
2022-08-16 7:02 pm |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
62,318 | $0 | $0 | 0 (Direct) |
View |
| 2022-08-12 Sale |
2022-08-16 6:59 pm |
Epizyme Inc. | EPZM | Richon Victoria Director |
22,608 | $0 | $0 | 0 (Direct) |
View |
| 2022-08-12 Sale |
2022-08-16 6:59 pm |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
8,994 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2022-08-12 Sale |
2022-08-16 6:58 pm |
Epizyme Inc. | EPZM | BEVERIDGE ROY A Director |
46,037 | $0 | $0 | 0 (Direct) |
View |
| 2022-08-12 Sale |
2022-08-16 6:57 pm |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
286,539 | $0 | $0 | 0 (Direct) |
View |
| 2022-08-12 Sale |
2022-08-16 6:55 pm |
Epizyme Inc. | EPZM | Beaulieu Joseph See Remarks |
52,076 | $0 | $0 | 0 (Direct) |
View |
| 2022-08-12 Sale |
2022-08-16 6:55 pm |
Epizyme Inc. | EPZM | BATE KENNETH Director |
17,054 | $0 | $0 | 0 (Direct) |
View |
| 2022-08-12 Sale |
2022-08-16 6:54 pm |
Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer |
120,067 | $0 | $0 | 0 (Direct) |
View |
| 2022-08-12 Sale |
2022-08-16 6:54 pm |
Epizyme Inc. | EPZM | Stuckley Carol Director |
25,696 | $0 | $0 | 0 (Direct) |
View |
| 2022-08-12 Sale |
2022-08-16 6:52 pm |
Epizyme Inc. | EPZM | Bogle Grant C. President and CEO |
259,170 | $0 | $0 | 0 (Direct) |
View |
| 2022-04-11 Sale |
2022-04-13 5:49 pm |
Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer |
2,741 | $0.9 | $2,467 | 94,563 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-08-12 Equity Swap |
2022-08-16 6:59 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
322,453 | $0 | 0 (Direct) |
View |
| 2022-08-12 Equity Swap |
2022-08-16 6:55 pm |
N/A N/A |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner |
31,933,334 | $0 | 0 (Indirect) |
View |
| 2022-08-09 Exercise |
2022-08-11 9:00 pm |
N/A N/A |
Epizyme Inc. | EPZM | Bogle Grant C. See Remarks |
417,500 | $1.41 | 259,170 (Direct) |
View |
| 2022-08-09 Tax Withholding |
2022-08-11 9:00 pm |
N/A N/A |
Epizyme Inc. | EPZM | Bogle Grant C. See Remarks |
746,307 | $1.39 | 259,170 (Direct) |
View |
| 2022-08-09 Tax Withholding |
2022-08-11 9:00 pm |
N/A N/A |
Epizyme Inc. | EPZM | Bogle Grant C. See Remarks |
395,083 | $1.41 | 259,170 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-11 9:00 pm |
N/A 2032-03-16 |
Epizyme Inc. | EPZM | Bogle Grant C. See Remarks |
1,217,500 | $0 | 259,170 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-11 9:00 pm |
N/A N/A |
Epizyme Inc. | EPZM | Bogle Grant C. See Remarks |
800,000 | $1.39 | 259,170 (Direct) |
View |
| 2022-08-09 Tax Withholding |
2022-08-11 8:53 pm |
N/A N/A |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
373,154 | $1.39 | 1,129,035 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-11 8:53 pm |
N/A 2032-03-16 |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
500,000 | $0 | 1,129,035 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-11 8:53 pm |
N/A N/A |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
500,000 | $1.39 | 1,129,035 (Direct) |
View |
| 2022-08-09 Tax Withholding |
2022-08-11 8:53 pm |
N/A N/A |
Epizyme Inc. | EPZM | Beaulieu Joseph See Remarks |
279,864 | $1.39 | 51,099 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-11 8:53 pm |
N/A 2032-03-16 |
Epizyme Inc. | EPZM | Beaulieu Joseph See Remarks |
300,000 | $0 | 51,099 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-11 8:53 pm |
N/A N/A |
Epizyme Inc. | EPZM | Beaulieu Joseph See Remarks |
300,000 | $1.39 | 51,099 (Direct) |
View |
| 2022-08-09 Tax Withholding |
2022-08-11 8:52 pm |
N/A N/A |
Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer |
354,496 | $1.39 | 120,067 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-11 8:52 pm |
N/A 2032-03-16 |
Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer |
380,000 | $0 | 120,067 (Direct) |
View |
| 2022-08-09 Exercise |
2022-08-11 8:52 pm |
N/A N/A |
Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer |
380,000 | $1.39 | 120,067 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:06 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
16,156 | $1.47 | 331,447 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:06 pm |
N/A N/A |
Epizyme Inc. | EPZM | BEVERIDGE ROY A Director |
8,928 | $1.47 | 46,037 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:02 pm |
N/A N/A |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
10,204 | $1.47 | 62,318 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 6:01 pm |
2023-05-17 2032-05-16 |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner |
41,006 | $0.56 | 31,980,464 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 6:01 pm |
2023-05-17 N/A |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner |
8,994 | $0 | 31,980,464 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:30 pm |
N/A 2032-05-16 |
Epizyme Inc. | EPZM | BATE KENNETH Director |
50,000 | $0 | 58,060 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:29 pm |
N/A 2032-05-16 |
Epizyme Inc. | EPZM | Richon Victoria Director |
50,000 | $0 | 63,614 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:29 pm |
N/A 2032-05-16 |
Epizyme Inc. | EPZM | Stuckley Carol Director |
50,000 | $0 | 66,702 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:28 pm |
N/A 2032-05-16 |
Epizyme Inc. | EPZM | Giordano Michael F Director |
50,000 | $0 | 58,060 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:26 pm |
N/A 2032-05-16 |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
50,000 | $0 | 356,297 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:26 pm |
N/A 2032-05-16 |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
50,000 | $0 | 93,120 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:23 pm |
N/A 2032-05-16 |
Epizyme Inc. | EPZM | GOLDFISCHER CARL Director |
50,000 | $0 | 3,444,011 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:20 pm |
N/A 2032-05-16 |
Epizyme Inc. | EPZM | BEVERIDGE ROY A Director |
50,000 | $0 | 78,115 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-04 6:48 pm |
N/A 2032-03-31 |
Epizyme Inc. | EPZM | Korn Jerald Chief Operating Officer |
800,000 | $0 | 800,000 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-01 5:31 pm |
N/A N/A |
Epizyme Inc. | EPZM | BEVERIDGE ROY A Director |
11,413 | $1.15 | 28,115 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-01 5:30 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
20,653 | $1.15 | 306,297 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-01 5:30 pm |
N/A N/A |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
13,043 | $1.15 | 43,120 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-21 6:06 pm |
N/A 2032-03-16 |
Epizyme Inc. | EPZM | Bogle Grant C. See Remarks |
800,000 | $0 | 800,000 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-21 6:06 pm |
N/A N/A |
Epizyme Inc. | EPZM | Beaulieu Joseph See Remarks |
2,331 | $1.2665 | 330,963 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-21 6:06 pm |
N/A 2032-03-16 |
Epizyme Inc. | EPZM | Beaulieu Joseph See Remarks |
300,000 | $0 | 330,963 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-21 6:05 pm |
N/A 2032-03-16 |
Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer |
380,000 | $0 | 380,000 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-21 6:05 pm |
N/A N/A |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
2,331 | $1.2665 | 658,716 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-21 6:05 pm |
N/A 2032-03-16 |
Epizyme Inc. | EPZM | Agarwal Shefali See Remarks |
500,000 | $0 | 658,716 (Direct) |
View |